This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Stemcell Technologies Canada Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovator Spotlight: Charis-Patricia Segeritz
Introduction:
Charis-Patricia Segeritz is a talented inventor based in Vancouver, Canada, known for his groundbreaking work in the field of organoid technology. With a patent focused on compositions and methods for obtaining organoids, Charis-Patricia has made significant contributions to the scientific community.
Latest Patents:
Charis-Patricia Segeritz holds one patent for his innovative method for obtaining epithelial organoids. The patent outlines a process for culturing epithelial ducts, fragments, and stem cells in contact with an extracellular matrix in the absence of FGF and/or nicotinamide. This novel approach has paved the way for advancements in organoid research and holds great promise for future applications in medicine and biotechnology.
Career Highlights:
Currently affiliated with Stemcell Technologies Canada Inc., Charis-Patricia Segeritz continues to push the boundaries of innovation in the field of regenerative medicine. His dedication to advancing organoid technology has earned him recognition as a leading expert in the field.
Collaborations:
Charis-Patricia Segeritz has had the privilege of working alongside esteemed colleagues such as Ryan Conder and Michael Riedel. Through collaborative efforts, they have furthered research in organoid technology and expanded the potential applications of this cutting-edge technology.
Conclusion:
In conclusion, Charis-Patricia Segeritz stands out as a visionary inventor in the field of organoid technology. His pioneering work in obtaining epithelial organoids has laid the foundation for future advancements in regenerative medicine. With a brilliant mind and a passion for innovation, Charis-Patricia continues to make a lasting impact on the scientific community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile